Severe Hypophosphatemia After Ferric Carboxymaltose Infusion: A Case Report.

Ferric carboxymaltose (FCM) allows for rapid and total correction of iron deficiency with a lower risk of hypersensitivity reactions compared to other IV iron preparations. However, FCM is associated with potentially serious adverse events, including hypophosphatemia, following the infusion. The mechanism behind FCM-induced hypophosphatemia is not well understood, but pre-existing risk factors can increase the likelihood of severe and persistent hypophosphatemia.

[Do physicians know the cost of the treatments and tests they prescribe?].

Objective: To determine the degree of knowledge among physicians regarding the cost of diagnostic tests and commonly used drugs.

Individuals And Methods: An interview was obtained with a representative sample of 164 physicians from a total of 338 (accuracy +/- 3.55), distributed in interns/residents (n:119) and staff members (n:45) from the divisions of Surgery (n:81) and Medicine (n:83) at Hospital Clinic i Provincial, Barcelona.